Characteristics | Patients |
---|---|
Age (years) | |
Mean ± SD | 60.9 ± 11.9 |
Median (range) | 62 (28–81) |
Sex | |
Women | 37/85 (43.5%) |
Men | 48/85 (56.5%) |
WHO performance status | |
0 | 56/85 (65.9%) |
1 | 29/85 (34.1%) |
Tumor location | |
Head and neck | 2/85 (2.4%) |
Shoulder girdle | 9/85 (10.6%) |
Pelvic girdle | 7/85 (8.2%) |
Trunk wall | 9/85 (10.6%) |
Upper limb | 10/85 (11.8%) |
Lower limb | 48/85 (56.5%) |
Tumor depth | |
Deep | 65/85 (76.5%) |
Deep and superficial | 18/85 (21.2%) |
Superficial | 2/85 (2.4%) |
Tumor size (mm) | |
Mean ± SD | 114 ± 56 |
Median (range) | 99 (32–274) |
Histological type | |
Undifferentiated pleomorphic sarcoma | 40/85 (47.1%) |
Rhabdomyosarcoma | 9/85 (10.6%) |
Leiomyosarcoma | 7/85 (8.2%) |
M-RC/LPS | 7/85 (8.2%) |
Synovial sarcoma | 7/85 (8.2%) |
Pleomophic liposarcoma | 6/85 (7.1%) |
Other undifferentiated sarcomas | 4/85 (4.7%) |
Angiosarcoma | 2/85 (2.4%) |
High-risk solitary fibrous tumor | 1/85 (1.2%) |
MPNST | 1/85 (1.2%) |
Myxofibrosarcoma | 1/85 (1.2%) |
Curative surgery | |
No | 11/85 (12.9%) |
Yes | 74/85 (87.1%) |